Baystreet Staff - Thursday, October 14, 2010 PharmaGap Inc. 01:05 PM EST - PharmaGap Inc. : announced positive results from the toxicity phase of testing of the Company's cancer drug GAP-107B8 at LAB Research Inc. of Montreal, PQ. PharmaGap Inc. shares V.GAP are trading up $.015 at $0.15.